Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dylan Hartley currently holds 110,000 shares of OnKure Therapeutics, Inc. (OKUR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dylan Hartley has been a net neutral trader of OKUR stock. They have purchased $0 and sold $0 worth of shares.
Dylan Hartley's most recent insider trade was on Apr 1, 2026, when they sold 110,000 shares at $0.00 per share.
Dylan Hartley serves as Executive at OnKure Therapeutics, Inc. (OKUR). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Dylan Hartley holds the position of Executive at OnKure Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Dylan Hartley has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Dylan Hartley was on Apr 1, 2026, when they purchased $0 worth of OKUR shares. This transaction involved 110,000 shares at N/A per share.
Dylan Hartley currently owns 110,000 shares of OnKure Therapeutics, Inc. (OKUR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dylan Hartley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dylan Hartley has 2 Form 4 filings on record as an insider at OnKure Therapeutics, Inc..
Set alerts for Dylan Hartley and 40,000+ other insiders.